Related Experiment Video
Updated: Jul 14, 2026

11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.5K
Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study
Pim van Oirschot1, Marco Heerings2,3, Karine Wendrich4
1Orikami Digital Health Products, Nijmegen, Netherlands.
JMIR Mhealth and Uhealth
|October 5, 2020
Summary
A smartphone app variant of the Symbol Digit Modalities Test (SDMT) shows strong construct validity and test-retest reliability for monitoring cognitive processing speed (CPS) in multiple sclerosis (MS) patients.
Area of Science:
- Neurology
- Digital Health
- Cognitive Neuroscience
Background:
- Cognitive processing speed (CPS) decline is a common issue in multiple sclerosis (MS).
- The Symbol Digit Modalities Test (SDMT) is a standard tool for assessing CPS.
- A smartphone application (MS sherpa) was developed to implement a variant of the SDMT.
Purpose of the Study:
- To evaluate the construct validity of the smartphone SDMT variant (sSDMT).
- To assess the test-retest reliability of the sSDMT.
- To explore user experiences with the sSDMT in individuals with MS.
Main Methods:
- A validation study involved 25 individuals with relapsing-remitting MS and 79 healthy controls (HC).
- Construct validity was assessed by comparing sSDMT scores with the paper-and-pencil SDMT.
- Test-retest reliability was determined through repeated sSDMT assessments over time.
Main Results:
- The sSDMT demonstrated strong construct validity with a high intraclass correlation coefficient (ICC) of 0.838.
- Excellent test-retest reliability was observed across different participant groups (MS, HC matched, HC normative) with ICCs ranging from 0.857 to 0.874.
- Participants reported a positive experience with the sSDMT, emphasizing the need for user-centered adaptation.
Conclusions:
- The sSDMT exhibits robust construct validity and test-retest reliability.
- The sSDMT is a promising tool for monitoring cognitive processing speed in MS.
- The sSDMT can be utilized in both clinical research and practice for individuals with MS.

